Editorial: NAFLD, chronic kidney disease, and pleiotropy-Why is PNPLA3 omnipresent?

Pirola CJ, Sookoian S

Open source

DOI
10.1111/apt.17491
Published
2023 May
Container
Alimentary pharmacology & therapeutics
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/apt.17491,
  title = {Editorial: NAFLD, chronic kidney disease, and pleiotropy-Why is PNPLA3 omnipresent?},
  author = {Pirola CJ and Sookoian S},
  year = {2023},
  journal = {Alimentary pharmacology \& therapeutics},
  doi = {10.1111/apt.17491},
  url = {https://doi.org/10.1111/apt.17491}
}

RIS

TY  - JOUR
TI  - Editorial: NAFLD, chronic kidney disease, and pleiotropy-Why is PNPLA3 omnipresent?
AU  - Pirola CJ
AU  - Sookoian S
PY  - 2023
JO  - Alimentary pharmacology & therapeutics
DO  - 10.1111/apt.17491
UR  - https://doi.org/10.1111/apt.17491
ER  - 

APA

CJ, P., & S, S. (2023). Editorial: NAFLD, chronic kidney disease, and pleiotropy-Why is PNPLA3 omnipresent?. Alimentary pharmacology & therapeutics. https://doi.org/10.1111/apt.17491

Source records